LILLY AUTHENTIC MEDICATION SHIPPED DIRECT
Live / Applied — First extension granted (statement of use) (as of 17 Dec 2025)
What this means for you
Not registered yet, but its 03 Jan 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98935419
- Mark type
- Design + words
- Filed
- 03 Jan 2025
- Published for opposition
- 27 May 2025
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: Housemark for a full line of pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
- Class 035 — Advertising and business services: Retail pharmacy services; online retail pharmacy services; mail order pharmacy services; online retail store services featuring pharmaceuticals; online retail pharmacy services for the ordering, purchase, and delivery of pharmaceuticals; pharmaceutical services, namely, processing prescription orders
- Class 044 — Medical, beauty and agricultural services: Healthcare services; medical services; telemedicine services; arranging and providing medical information services relating to pharmaceuticals, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Owner
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 17 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2025 — SOU EXTENSION 1 GRANTED
- 17 Dec 2025 — SOU EXTENSION 1 FILED
- 17 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Jul 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 May 2025 — PUBLISHED FOR OPPOSITION
- 21 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Apr 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Apr 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Apr 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Apr 2025 — NON-FINAL ACTION E-MAILED
- 15 Apr 2025 — NON-FINAL ACTION WRITTEN